Inicio › Enfermedad de células falciformes › Tennessee
Ensayos clínicos de Enfermedad de células falciformes en Tennessee
22 estudios sobre Enfermedad de células falciformes buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
- St Jude Children's Research Hospital, Memphis
ReclutandoFase 2
Hasta los 22 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07616154HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
ReclutandoEstudio observacional
Edades de 12 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07145411The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of Tennessee Health Science Center- Site Number : 8400045, Memphis
ReclutandoFase 3
Edades de 10 a 65 · Todos los sexos · Actualizado el 15 oct 2026 · NCT06975865Gene Editing For Sickle Cell Disease
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Edades de 18 a 24 · Todos los sexos · Actualizado el 15 oct 2026 · NCT06506461A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- University of Tennessee Health Science Center, Memphis
- St. Jude Children's Res Hosp, Memphis
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06612268Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Edades de 8 a 17 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07226219SCD Stem Cell Mobilization and Apheresis Using Motixafortide
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06442761ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- St. Jude Children's Research Hospital, Memphis
- Vanderbilt University Medical Center, Nashville
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 17 ago 2026 · NCT04398628Gene Therapy Communication: Use of a Needs Assessment to Drive Decision-AIDS for Gene Therapy for Rare Diseases (GENETX)
- St. Jude Children's Research Hospital, Memphis
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 8 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT05810181Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease
- St. Jude Children's Research Hospital, Memphis
ReclutandoEstudio observacional
Edades de 12 a 25 · Todos los sexos · Actualizado el 29 jun 2026 · NCT06477289Investigation of the Genetics of Hematologic Diseases
- St. Jude Children's Research Hospital, Memphis
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 9 jun 2026 · NCT02720679Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- St Jude Children Hospital (NT-DMT), Memphis
- St. Jude Children's Research Hospital (MRD-HCT), Memphis
ReclutandoEstudio observacional
Edades de 3 a 20 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06941389Sickle Cell Clinical Research and Intervention Program
- Regional One Health, Diggs-Kraus Sickle Cell Center, Memphis
- Methodist Adult Comprehensive Sickle Cell Center, Memphis
- St. Jude Children's Research Hospital, Memphis
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 4 jun 2026 · NCT02098863Functional Ovarian Reserve in Sickle Cell Disease
- St. Jude Children's Research Hospital, Memphis
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 10 a 18 · Mujeres · Actualizado el 4 jun 2026 · NCT07392216Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
- St. Jude Children's Research Hospital, Memphis
Reclutando
Edades de 6 a 25 · Todos los sexos · Actualizado el 18 may 2026 · NCT03353584Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 18 a 21 · Todos los sexos · Actualizado el 6 may 2026 · NCT05583721Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
- St. Jude Children's Research Hospital, Memphis
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 13 en adelante · Todos los sexos · Actualizado el 1 may 2026 · NCT04416178School Readiness Intervention for Preschool Children With Sickle Cell Disease
- St. Jude Children's Research Hospital, Memphis
Reclutando
42 Months – 78 Months · Todos los sexos · Actualizado el 24 abr 2026 · NCT06367192Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- Vanderbilt University, Nashville
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 mar 2026 · NCT06919224Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- TriStar Medical Group Children's Specialists - Pediatric Oncology, Nashville
ReclutandoFase 3
Edades de 12 a 35 · Todos los sexos · Actualizado el 23 mar 2026 · NCT05477563A Long-term Follow-up Study in Patients Who Received BEAM-101
- St. Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
ReclutandoEstudio observacional
Edades de 14 a 37 · Todos los sexos · Actualizado el 28 ene 2026 · NCT07373639Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Tennessee at Memphis, Memphis
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jun 2025 · NCT06385886De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.